Annalisa Meola
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
MECHANISMS OF TECOVIRIMAT ANTIVIRAL ACTIVITY AND POXVIRUS RESISTANCE.
Journal: Research square
Published: October 14, 2024
Structural insights into tecovirimat antiviral activity and poxvirus resistance.
Journal: Nature microbiology
Published: August 30, 2024
Monkeypox Virus Infection Stimulates a More Robust and Durable Neutralizing Antibody Response Compared to Modified Vaccinia Virus Ankara Vaccination.
Journal: The Journal of infectious diseases
Published: July 10, 2024
Modulation of SARS-CoV-2 spike binding to ACE2 through conformational selection.
Journal: Nature nanotechnology
Published: May 13, 2024
Production and Purification of Hantavirus Glycoproteins in Drosophila melanogaster S2 Cells.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: February 05, 2024
TMPRSS2 is a functional receptor for human coronavirus HKU1.
Journal: Nature
Published: April 07, 2023
Seroepidemiology of the Seasonal Human Coronaviruses NL63, 229E, OC43 and HKU1 in France.
Journal: Open forum infectious diseases
Published: March 15, 2023
SARS-CoV-2 Omicron BA.1 breakthrough infection drives late remodeling of the memory B cell repertoire in vaccinated individuals.
Journal: Immunity
Published: January 27, 2023
A synthetic delivery vector for mucosal vaccination.
Journal: Biomaterials
Published: January 25, 2023
Qualitative monitoring of SARS-CoV-2 mRNA vaccination in humans using droplet microfluidics.
Journal: JCI insight
Published: October 24, 2022
Analysis of mRNA vaccination-elicited RBD-specific memory B cells reveals strong but incomplete immune escape of the SARS-CoV-2 Omicron variant.
Journal: Immunity
Published: December 21, 2021
Last Updated: 09/26/2026